Search Results

BioMech Health, LLC, a division of BioMech Holdings, LLC, announced that Atlanta-based Independent Neurodiagnostic Clinic and BioMech have partnered to deliver state-of-the-art clinical motion analytics to advance patient treatment.

BioMech Holdings, LLC, which develops and distributes real-time motion analytics that quantify and improve patient outcomes in the healthcare, sports, wellness, and industrial sectors, is announcing the appointment of Athanassios Diplas, PhD to its board of directors.

BioMech Health, a division of BioMech Holdings, LLC which provides clinically actionable solutions to improve health, quality of life and performance, announced that it has received the award for “Best Overall Biometric Solution” in the fifth annual AI Breakthrough Awards.

Integrating BioMech Lab™ into the SSS shoulder device delivers automated functional motion data collection and analysis to measure therapeutic progress.

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.

Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.

Bruker Corporation announced it will present at the following conferences.

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.